the US, the prevalence oIIDDM by age 20 years is -0.26%, and lifetime prevalence approaches 0.4% [1] . IDDM results from selective destruction of the insulin-producing J3-cells of the pancreas. After a chronic, clinically silent autoimmune pathology, patients usually have abrupt onset of hyperglycemia caused by insulinopenia [2, 3] . The patient becomes dependent on insulin therapy to restore normal metabolic hemostasis, which, if not maintained, can lead to ketoacidosis, retinopathy, neuropathy, nephropathy, and even death / [4] [5] [6] . The appearance of circulating islet cell autoantibodies (ICA) correlates with lymphocytic infiltration of the pancreas (insulitis) [7, 8] and increased risk for developing IDDM
/9-11/.
Among the most-studied islet cell autoantibodies are uncharacterized autoantibodies [12] [13] [14] , insulin autoantibodies
[15/, and GAD(,S autoantibodies (GAD6#{231}Ab5) [16] [17] [18] , all of which may vary in titer by several orders of magnitude.
The measurement of GAD(,5Abs as an alternative to ICA has been the focus of intense research because of the availability of purified native and recombinant GAD(,c [19, 20] , which provides an opportunity for development of a simple immunoassay. By comparison, the currently used indirect immunofluorescence assay of ICA is technically demanding, requires a pancreas from blood type 0 human cadavers, permits only a subjective estimate of antibody concentration, is difficult to standardize, and is not amenable to convenient screening of large numbers of sera. In limited studies, GAD(,cAb5 have been shown to be present in many newly diagnosed and prediabetic patients [21, 22] , and their presence appears to have greater sensitivity, specificity, and predictive value for IDDM than that of other autoantibodies [16] . However, the only GAD(,5Abs assays that have been reported to have acceptable clinical performance are radiohinding assays (RBAs). These methods are slow and labor intensive, and the reagents are unstable and environmentally problematic.
Although numerous ELISAs for GAD65Abs have been reported, none has the sensitivity approaching that of RBAs [23, 24] . We have developed a novel ELISA format that offers sensitivity and specificity comparable with those of RBAs. Our approach focuses on the detection of free antigen that has not become bound by antibodies. ELISA for GAD(,5 autoantibodies Materials and Methods
GAD65
Clones coding for human GAD65 were kindly provided by A. Tobin [20] 
GAD65MAB-PEROXIDASE CONJUGATE
Murine monoclonal anti-GAD(5 antibodies (GAD65MAb) were prepared by using GAD65 with RIBI adjuvant (RIBI Immunochem, Hamilton, MT) as immunogen. The concentration for use in the DELISA was determined empirically to maximize the ratio of specific to nonspecific binding on the streptavidincoated microtiter plates.
ASSAY METHODS
All steps were carried out at ambient temperature (22-25 #{176}C osol. After 1 h of shaking, the plate was washed with the same buffer, GAD65MAb-HRP conjugate (100 pL) was added to each well, and the plate was again shaken for b h and washed as before. The enzyme activity in each well was determined by incubation for 30 mm with equal volumes of tetramethylbenzidine and H202 (Kirkegaard and Perry Labs., Gaithersburg, MD), stopping the reaction with 0.1 mL of 0.5 mol/L H2 SO4, and reading the absorbance with a Syva MicroTrak#{174}EIA reader at 450 nm.
ELISAs were carried out by first incubating streptavidincoated microtiter plates with 100 .tL of 200 pmol/L bGAD65 in an equivolume mixture of goat serum and PBS for I h with shaking. After the wells were washed, diluted solutions of test sera in PBS (100 .tL) were added and incubated for 1 h. The wells were washed again and incubated with 100 jLL of a 1:5000 mixture of goat anti-human IgG-HRP conjugate (Kirkegaard and Perry Labs.) in PBS. After a final washing, the enzyme activity in the wells was determined as above.
Results

ASSAY CONCEPT
In the DELISA protocol, the binding of a low concentration of bGAD65 to antibodies in the sample is allowed to approach equilibrium before (Fig. 1) . The calibrators were also assayed by a conventional sandwich ELISA in which bGAD66 was first allowed to bind to streptavidin-coated wells. Serum calibrators diluted 10-, 100-, or 400-fold in assay buffer were then incubated in the wells for b h, and the wells were washed, incubated with goat-anti-human
IgG-HRP conjugate, and washed again, after which the enzyme activity was determined. Although the observed absolute signals were proportional to the serum concentrations, the ratios of signals between the highest calibrator and the negative calibrator (signal/background) were independent of serum concentration and were consistently only -1.6. No improvement was achieved by the use of various blocking reagents. Thus the assay sensitivity appeared to be limited by the inability to affect the ratio of rates of nonspecific IgG and specific GAD6 5Ab binding by varying the serum concentration.
ASSAY REPRODUCIBILITY
A set of five serum calibrators assayed in triplicate was run on nine different plates over a period of 14 days with the DELISA procedure using Protein A-dextran. The bGAD(,S was stored between runs at -70 #{176}C and thawed at room temperature before use. The assay response of each of the four positive calibrators was recorded as a fraction of the negative calibrator signal to Relative GADab concentration adjust for day-to-day differences in temperature and photomultiplier response. No significant drift was observed for any of the calibrators (Fig. 2) . The SD of the normalized signals within a single plate and between plates over the course of the study did not differ significantly ( The cutoff value is shown by the broken horizontal line.
Discussion
Antibodies are frequently assayed by incubating the sample with a surface-bound antigen and detecting the total bound IgG with labeled anti-immunoglobulin antibody. Theoretically, the highest signal-to-background ratio is obtained during the initial incubation period, during which the ratio of the rates of specific to nonspecific binding remains constant.
As the reaction approaches equilibrium, the rate of specific binding drops and the signal-to-background ratio becomes less favorable. Increasing the concentration of the sample increases the rates of both specific and nonspecific binding proportionately without affecting the ratio. The insensitivity of the GAD6 5Ab ELISA signalto-background ratio to the serum concentration in the present study was consistent with this prediction. One way to reduce the background signal is by using a labeled antigen in place of a labeled anti-immunoglobulin to detect bound antibody. However, excess antigen, if present, can that differs from a negative signal by >3 SD (-0. 15) can be considered significant, the detection limit for these antibodies was -0.5 ng/mL (3 pmolJL).
APPLICATION OF DELISA TO PATIENTS' SAMPLES
Sample sets from presumably normal adult controls were obtained from Irvine Scientific and the University of Florida. The average signals from each set, relative to a negative pooled serum calibrator (= 100), were 99 ± 5 (n = 20) and 106 ± 4 (n = 19), respectively.
Control samples from normal children (also obtained from Florida) had an average signal of 94 ± 8 (n = 30). The Florida samples had been stored frozen for as long as 10 years. The Irvine controls were from recent blood donors and were stored frozen until use.
Samples provided by The Second International Diabetes Workshop of GAD Antibody Measurement Standardization (IDW) [24] were analyzed in a blind study in which all samples, calibrators, and controls were measured in duplicate. The samples were received lyophilized and were rehydrated overnight with distilled water at 4 #{176}C before assay. A cutoff value to distinguish negatives from positives was arbitrarily set at 80% of the signal from the negative calibrator.
The results are illustrated in Fig. 5 Unfortunately, this method is quite labor intensive and usually requires the use of isotopic labels.
The present depletion ELISA differs from immunoprecipitation in two ways. First, a soluble immunoglobulin-binding reagent, Protein A-dextran, is used that sequesters the bound antigen without a separation step. The need for washing the bound antigen is thus eliminated without sacrificing sensitivity.
Second, the very low antigen concentration used minimizes nonspecific binding of the antigen and assures that the largest possible fraction of the antigen becolnes bound to antibody, even though the absolute amount of bound antigen is very low.
This configuration is consistent with the binding equation, which predicts that the fraction of antigen that is bound at equilibrium is maximized when the antigen concentration is less than both the antibody concentration and the antibody dissociation constant.
For very-high-affinity antibodies the detection limit therefore depends primarily on the ability to detect the antigen. In the present procedure, depletion of ---10% of the 12.5 pmol/L bGAD6S used in the assay, -1 pmoL'L, was reliably detected. Because the DELISA does not develop a high background signal in the presence of excess immunoglobulins, it was possible to use up to 50% serum in the initial binding step and thus take full advantage of this high sensitivity.
For low-affinity antibodies the detectability by DELISA is limited by the dissociation constant. Although the use of an antigen excess theoretically avoids this limitation, in practice the accompanying increase in nonspecific binding and the dissociation of weakly bound antigen during washing outweighs any theoretical
advantages. An additional limitation of the method is that the use of very low antigen concentrations prevents the assays from being fully quantitative.
The amount of antibody in the sample can only be stated to be equal to or greater than the total antigen uptake.
The effect of Protein A-dextran to significantly decrease the binding of bGAD65:antibody immune complex to the streptavidin-coated wells is presumably a result of steric interference produced by the dextran. Those antibody samples that inhibited the bGAD65 signal with no Protein A-dextran probably bound to the same epitope as the HRP-GAD65Ab conjugate and blocked binding of the conjugate.
Of critical importance in using the present assay to predict the onset of IDDM is establishing a cutoff value for differentiating normal and affected populations.
Putatively normal sample sets from three locations-the Peninsula Blood Bank in northern California, Irvine Scientific in southern California, and the University of Florida-were assayed at various times. Although the responses among each set were self-consistent over time, the different sample sets had significantly different mean assay responses, due possibly to differences in sample population, sample collection, or storage. The low cutoff of 80% of the negative calibrator signal used for the IDW samples provided a margin of safety that would account for these disease-unrelated variables. Among all of the IDW samples, this cutoff provided 94% specificity and 84% sensitivity (excluding the calibrators, all of which were correctly identified).
Because of the relatively small dynamic range of the assay, the overall assay performance does not strongly depend on the cutoff value used. A 75% cutoff appeared to give the best overall performance (Fig. 6 ).
In summary, this work provides a simple, accurate, and automatable method for the assay of GAD6SAb and thus makes possible wide-scale testing of this important analyte for prediction of onset of IDDM. The assay is being evaluated in several laboratories;
in one study it has been found to be highly useful as a screen for normal school children [30] . Further evaluation will be required to fully establish the general utility of GAD65Ab as a diagnostic marker.
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